Search clinical trials for: Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)

Total 188 results

Central South University

Unknown

Antipsychotic to Treat Psychosis Syndrome

Psychotic Disorders

China
Sumitomo Pharma America, Inc.

Completed

A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

Schizophrenia

United States
Sumitomo Pharma America, Inc.

Completed

A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard

Schizophrenia

United States
Cliniques universitaires Saint-Luc- Université...

Completed

β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS (SANAT)

Schizophrenia

Belgium
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.

Schizophrenia | Schizoaffective Disorder

United States
University of Pittsburgh
Janssen Pharmaceuticals

Completed

Risperdal Consta for Bipolar Disorder

Bipolar I Disorder

United States
Bristol-Myers Squibb
Otsuka America Pharmaceutical

Terminated

A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome

Schizophrenia | Metabolic Syndrome

France, Hungary, Spain, Czech Republic, Belgium, Germany, Greece, Switzerland, Turkey
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome

Schizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar I Disorder

Canada
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Schizophrenia Trial of Aripiprazole

Schizophrenia

Austria, United Kingdom, France, Spain, Sweden, Czech Republic, Denmark, Finland, Germany
Northwell Health

Terminated

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

High Risk MC4R Genotype | Low Risk MC4R Genotype | One Week or Less Antipsychotic Lifetime Exposure

United States
Aziende Chimiche Riunite Angelini Francesco S.p.A

Completed

Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia" (SWITCH)

Schizophrenia

Italy
Matt Byerly
Otsuka America Pharmaceutical

Unknown

Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

Schizophrenia

United States
Janssen Research & Development, LLC

Completed

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Depressive Disorder | Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States, Belgium, Germany, Spain, Argentina, Brazil, Bulgaria
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder

Denmark, Iceland, Finland, Switzerland
University of Minnesota
AstraZeneca; Jensen, Jonathan B., M.D.

Completed

A Comparative Study of New Medications for Psychosis in Adolescents

Psychotic Disorders | Schizophrenia | Schizoaffective Disorders | Schizophreniform Disorders

United States
Qingyun Yin

Unknown

Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia (TAAS)

Schizophrenia

China
Yale University
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia

Schizophrenia
University of British Columbia
Bristol-Myers Squibb

Completed

Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI (CALM)

Psychotic Disorders | Bipolar Disorder | Metabolic Syndrome X

Canada
Dalian Seventh People's Hospital
TAKARA BIOTECHNOLOGY(DALIAN)CO.,LTD.

Unknown

The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients

Schizophrenia | Micrognathia

China
Ortho-McNeil Janssen Scientific Affairs, LLC

Withdrawn

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Schizophrenia
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

SWitching to Abilify Trial (SWAT)

Schizophrenia

Korea, Republic of
Central South University
Shanghai Mental Health Center; Capital Medical University; Nanjing Medical University and other collaborators

Completed

Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia (ACPIOS)

Schizophrenia

China
Janssen Scientific Affairs, LLC

Completed

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

Schizophrenia

United States, Puerto Rico
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

Glucose and Lipid Metabolism on Antipsychotic Medication (Glulipid)

Hyperglycemia | Schizophrenia | Schizoaffective Disorder | Type 2 Diabetes Mellitus

United States
Johns Hopkins University
National Institute of Mental Health (NIMH); University of Maryland; University... and other collaborators

Completed

Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics (IMPACT)

Psychotic Disorders

United States
Centre Hospitalier Universitaire de Nice

Completed

Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic

Schizophrenia | Dissociative Disorders

France
Janssen Korea, Ltd., Korea

Terminated

A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug

Schizophrenia

Korea, Republic of
Ohio State University

Recruiting

An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

Treatment-resistant Schizophrenia

United States
Juntendo University

Completed

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

Schizophrenia Relapse
Veterans Medical Research Foundation
Bristol-Myers Squibb

Completed

Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics

Diabetes

United States
Emory University
Abbott

Completed

A Comparison of Two Standard Therapies in the Management of Dementia With Agitation

Dementia | Alzheimer Disease | Dementia, Alzheimer Type | Senile Dementia, Alzheimer Type

United States
Georgetown University
National Institute of Mental Health (NIMH); Washington D.C. Veterans Affairs...

Completed

Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia (STAR-1)

Schizophrenia

United States
Janssen-Cilag International NV

Completed

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia

France, Poland, Germany, Spain, Slovenia, Bulgaria, Romania, Israel, Greece, Sweden, Turkey, Czech Republic, Hungary, Lithuania, Latvia, Portugal, Croatia, Slovakia, Austria, United Kingdom, Estonia, Ireland, Denmark, Saudi Arabia
Inje University

Terminated

Quality of Life (QOL) in Female Patient With Schizophrenia

Schizophrenia

Korea, Republic of
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States, India, Romania
Northwell Health

Completed

Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade

Schizophrenia

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

Schizophrenia

United States
AstraZeneca

Completed

A Comparison of Seroquel vs. Risperidone in Schizophrenia

Schizophrenia

United States
Peking University

Not yet recruiting

The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset

Treatment-resistant Schizophrenia
Centre for Addiction and Mental Health
Canadian Psychiatric Research Foundation

Completed

Antipsychotic Polypharmacy in Schizophrenia

Schizophrenia

Canada
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

Bipolar Disorder
Shanghai Mental Health Center

Completed

A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia

Schizophrenia

China
Northwell Health
National Institute of Mental Health (NIMH)

Completed

Treatment and Outcome of Early Onset Bipolar Disorder

Bipolar Disorder

United States
McMaster University
College of Family Physicians of Canada; MediSystem Pharmacy

Unknown

Deprescribing Antipsychotics in Long-Term Care

Dementia | Behavior

Canada
Northwell Health
National Institutes of Health (NIH)

Completed

Striatal Connectivity and Clinical Outcome in Psychosis

Psychotic Disorders

United States
AstraZeneca

Completed

A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

Metabolic Effects of Antipsychotics in Children (MEAC)

Aggression | Bipolar Disorder | Oppositional Defiant Disorder | Pervasive Development Disorders | Attention Deficit-Hyperactivity

United States
National Institute of Mental Health (NIMH)

Completed

CATIE- Schizophrenia Trial

Schizophrenia

United States
Northwell Health
National Institute of Mental Health (NIMH)

Completed

Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)

Schizophrenia | Schizoaffective Disorder

United States
Denovo Biopharma LLC

Completed

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

Schizophrenia

United States, Mexico, Germany, Russian Federation

Search clinical trials for: Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations